Keywords
cholecystosonography
biliary system
chronic cholecystitis
How to Cite
Abstract
Overlay of diseases of the biliary system to diabetes mellitus type 2 can contribute to the enhancement of disorders of protein, lipid and carbohydrate metabolism and affect the mechanisms of regulation at the cellular molecular level. Therefore, the need for early diagnosis and study of the features of the course of chronic cholecystitis against the background of diabetes mellitus type 2 is a pressing issue of internal medicine. The motor-evacuation and cholecretory functions of the biliary system and the features of the course of chronic cholecystitis on the background of diabetes mellitus type 2 were studied. 93 patients were examined, of which 62 were patients with combined diabetes mellitus type 2 and chronic cholecystitis and 31 patients with isolated chronic cholecystitis. The control group was represented by 20 apparantly healthy individuals, who were representative of the age and number of male and female probands. The course of chronic cholecystitis was found to be accompanied by impaired gallbladder motor (evacuation) function, which was manifested by an increase in the latency period, the volume of the cavity of the gallbladder, the emptying coefficients in the dynamics and a decrease in the index of contraction of the gallbladder. In the presence of diabetes mellitus type 2, an atypical course of chronic cholecystitis may be formed, characterized by motor-evacuation disorders of the biliary tract and physico-chemical changes in bile, the severity of which exceeds those of isolated chronic cholecystitis. The peculiarities of the course of chronic cholecystitis in patients with diabetes mellitus type 2 are manifested by insignificant clinical symptoms and distinct changes at both stages of cholecystosonography, which may be the result of the development of autonomic neuropathy. In diabetes mellitus type 2, it is advisable to determine the status of the gallbladder (cholecystosonography) in order to prevent the risk of complications (cholelithiasis) and timely administration of antimicrobial therapy in the presence of an additional inflammation.
References
Ohanov R.H., Denisov I.N., Simanenkov V.I., Bakulin I.H., Bakulina N.V., Bolduieva S.A. et al. (2017). Komorbidnaia patolohiia v klinicheskoi praktike. Klinicheskiie rekomendatsii [Comorbid pathology in clinical practice]. Kardiovaskuliarnaia terapiia i profilaktika – Cardiovascular Therapy and Prevention, vol. 16, № 6, pp. 5–56, DOI https://doi.org/10.15829/1728-8800-2017-6-5-56 [in Russian].
Paneni F., Beckman J.A., Creager M.A., Cosentino F. (2013). Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur. Heart J., № 34, pp. 2436–2446.
Ametov A.S., Prudnikova M.A. (2016). Sakharnyi diabet 2-ho tipa. Problemy i resheniia [Type 2 diabetes mellitus. Problems and Solutions]. Moscow: GEOTAR-Media, pp. 131–162 [in Russian].
Ametov A.S., Karpova Ye.V., Ivanova Ye.V. (2009). Effektivnoie i bezopasnoie upravleniie sakharnym diabetom 2 tipa na sovremennom urovne [Effective and safe management of type 2 diabetes at the current level]. Saharnyi diabet – Diabetes Mellitus, № 2 (43), pp. 18–24 [in Russian].
Khvorostinka V.M., Kryvonosova O.M. (2009). Patohenetychni ta terapevtychni aspekty khronichnykh zakhvoriuvan hastroduodenalnoi systemy u khvorykh na tsukrovyi diabet [Pathogenetic and therapeutic aspects of chronic diseases of the gastroduodenal system in patients with diabetes mellitus]. Problemy endokrynnoi patolohii – Endocrine pathology problems, № 1, pp. 18–23 [in Ukrainian].
Chhabra A., Grover S., Vilj A., Singh A.P. (2013). Gallbladder disease in type-2 diabetes mellitus patients. IJMDS, № 2 (1), pp. 7–15, DOI 10.18311/ijmds/2013/19815.
Davis T.M., Drinkwater J.J., Fegan P.G., Chikkaveerappa K., Sillars B., Davis W.A. (2019). Community-based management of complex type 2 diabetes: Adaptation of an integrated model of care in a general practice setting. Intern. Med. J., № 97 (5), pp. 1581–1588.
Wang W., Li N. (2014). The association of gallstone disease and diabetes mellitus. A meta-analysis. Saudi. Med. J., № 35 (9), pp. 1005–1012, PMID 25228184.
Zviahintseva T.D., Sharhorod I.I. (2015). Khronicheskii beskamennyi kholetsistit: klinika, diahnostika i lecheniie [Chronic stoneless cholecystitis: clinic, diagnosis and treatment]. Skhidnoievropeiskyi zhurnal vnutrishnoi ta simeinoi medytsyny – Eastern European Journal of Internal and Family Medicine, № 2, pp. 13–19 [in Russian].
Fadeienko H.D., Chernova V.M. (2015). Zhelchnokamennaia bolezn: mekhanizmy razvitiia, podkhody k terapii [Gallstone disease: development mechanisms, approaches to therapy]. Suchasna hastroenterolohiia – Modern Gastroenterology, № 5 (85), pp. 110–116 [in Russian].
Skvortsova T.E., Sitkin S.I., Radchenko V.H., Seliverstov P.V., Tkachenko Ye.I. (2013). Zhelchnokamennaia bolezn. Sovremennyie podkhody k diahnostike, lecheniiu i profilaktike: posobiie dlia vrachei [Cholelithiasis. Modern approaches to diagnosis, treatment and prevention: a manual for doctors]. Moscow: Forte print, 32 p. [in Russian].
Agunloye A.M., Adebakin A.M., Adeleye J.O. (2013). Ultrasound prevalence of gallstone disease in diabetic patients at Ibadan, Nigeria. Niger J. Clin. Pract., vol. 16 (1), pp. 71–75.
Zhang Z.H., Qin C.K., Wu S.D. (2014). Roles of sphincter of Oddi motility and serum vasoactive intestinal peptide, gastrin and cholecystokinin octapeptide. World J. Gastroenterol., vol. 20 (16), pp. 4730–4736.
Chen L., Peng Y.T., Chen F.L. (2015). Epidemiology, management and economic evaluation of screening of gallstone disease among type 2 diabetics: a systematic review. World J. Clin. Cases, № 16 (3), pp. 599–606.